NASDAQ: AMGN
Amgen Inc Earnings & Revenue

AMGN past earnings growth

How has AMGN's earnings growth performed historically?
Company
-2.91%
Industry
10.68%
Market
82.89%
AMGN's earnings have grown faster (10.05% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
AMGN's earnings have grown slower (10.05% per year) than the US market average (77.34%)
Performance
AMGN's earnings growth is slowing down - its growth over the last year (-2.91%) is below its 5-year compound annual rate (10.05%)
Performance

AMGN past revenue growth

How has AMGN's revenue growth performed historically?
Company
3.14%
Industry
6.62%
Market
16.55%
AMGN's revenue has grown slower (3.19% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
AMGN's revenue has grown slower (3.19% per year) than the US market average (15.67%)
Performance
AMGN's revenue growth is slowing down - its growth over the last year (3.14%) is below its 5-year compound annual rate (3.19%)
Performance

AMGN earnings and revenue history

Current Revenue
$24.3B
Current Earnings
$7.3B
Current Profit Margin
30%
AMGN's has demonstrated consistent long-term earnings growth over the past 10 years (160.68%)
Performance

AMGN Return on equity

Current Company
71.7%
Current Industry
10.9%
Current Market
-36.3%
AMGN's Return on Equity (71.7%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

AMGN Return on assets

Current Company
11.9%
Current Industry
8.5%
Current Market
6.2%
AMGN is generating higher Return on Assets (11.9%) than the US Drug Manufacturers - General industry average (8.27%)
Performance

AMGN Return on capital employed

Current Company
17.56%
Current Industry
12.8%
AMGN has gotten more efficient at generating Return on Capital (17.56%) compared to 3 years ago (15.33%)
Performance

AMGN earnings dates

Next earnings date
Oct 28, 2020

Amgen Earnings & Revenue FAQ

On Apr 30, 2020, Amgen (NASDAQ: AMGN) reported Q1 2020 earnings per share (EPS) of $3.09, up 3.44% year over year. Total Amgen earnings for the quarter were $1.83 billion. In the same quarter last year, Amgen's earnings per share (EPS) was $3.20.
On Apr 30, 2020, Amgen (NASDAQ: AMGN) reported Q1 2020 revenue of $6.16 billion up 10.87% year over year. In the same quarter last year, Amgen's revenue was $5.56 billion.
As of Q4 2020, Amgen's earnings has grown -2.91% year over year. This is 13.6 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. Amgen's earnings in the past year totalled $7.30 billion.
As of Q4 2020, Amgen's revenue has grown 3.14% year over year. This is 3.48 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. Amgen's revenue in the past year totalled $24.30 billion.
Amgen's earnings date is Oct 28, 2020. Add AMGN to your watchlist to be reminded of AMGN's next earnings announcement.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics